CompletedNCT04702243

Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults

Studying Primary ciliary dyskinesia

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of North Carolina, Chapel Hill
Principal Investigator: Kenneth Olivier, MD, MPH, M.D
University of North Carolina, Chapel Hill
Intervention: Genetic Testing for PCD or PID(diagnostic_test)
Enrollment: 436 enrolled
Eligibility: 5-45 years · All sexes
Timeline: 2020 – 2025

Study locations (8)

Stanford University, Palo Alto, California, United States
Children's Hospital Colorado, Aurora, Colorado, United States
National Heart, Lung and Blood Institute, Bethesda, Maryland, United States
Washington University in St. Louis, St Louis, Missouri, United States
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Seattle Children's Hospital, Seattle, Washington, United States
The Hospital for Sick Children, Toronto, Ontario, Canada
McGill University, Montreal, Quebec, Canada

Collaborators

Washington University School of Medicine · National Heart, Lung, and Blood Institute (NHLBI) · Children's Hospital Colorado · Stanford University · Seattle Children's Hospital · The Hospital for Sick Children · McGill University · Children's Hospital Medical Center, Cincinnati

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04702243 on ClinicalTrials.gov

Other trials for Primary ciliary dyskinesia

Additional recruiting or active studies for the same condition.

See all trials for Primary ciliary dyskinesia →

← Back to all trials